XTransfer gets CBUAE approval, giving UAE clinics a new cross-border payment option in 2026

XTransfer secured in-principle approval on 3 September 2026 for a Retail Payment Services Licence from the Central Bank of the UAE (CBUAE), a conditional step that could add another regulated cross-border payment provider for UAE healthcare operators once final conditions are met.

The story matters most to clinic CFOs, COOs and IT heads. Dubai clinics licensed by the Dubai Health Authority (DHA) already manage a mix of card payments, insurer receipts and overseas supplier transfers. Abu Dhabi providers regulated by the Department of Health Abu Dhabi (DOH) and northern emirates providers under the Ministry of Health and Prevention (MOHAP) face the same cash-cycle problem, with different local licensing and payer workflows.

What XTransfer has approval to pursue

The approval is not a final licence. XTransfer said the licence will allow it to serve mainland UAE clients after it completes CBUAE pre-issuance conditions. The company said its UAE plan is focused on regulated B2B payment services for cross-border trade.

“Receiving conditional approval from the Central Bank of the UAE is a key milestone for XTransfer's global regulatory expansion,” Bill Deng, founder and chief executive of XTransfer, said in the Manila Times release.

XTransfer said it processed more than $60 billion in total payment volume in 2025, citing CIC, and had more than 1 million registered SME customers globally. As of 31 March 2026, XTransfer said it provided payment services across more than 200 countries and regions, with licences or permissions in markets including mainland China, Hong Kong, the UK, the US, Singapore, the Netherlands, Australia and Canada.

The relevant UAE rulebook is the CBUAE's Retail Payment Services and Card Schemes Regulation, issued under Circular No. 15/2021. The regime covers retail payment services such as payment accounts, merchant acquiring, payment initiation, fund transfers, payment token services and card schemes. For clinics, the practical question is whether a new licensed provider can lower friction in payment acceptance and cross-border settlement without adding reconciliation risk.

Where clinics may feel the effect

Dubai outpatient clinics often carry three payment flows: patient collections at reception, insurer reimbursements and supplier payments for consumables, equipment or outsourced services. Clinics dealing with international suppliers in China, Europe or the US usually pay through banks, exchange houses or payment platforms. A CBUAE-licensed B2B provider could become relevant if it supports AED accounts, invoices, batch payments and compliance documentation that finance teams can audit.

• For CFOs, compare all-in transaction cost, FX spread, settlement time and chargeback handling against current bank and gateway contracts.
• For COOs, check whether payment confirmation can be tied to procurement approvals, inventory receiving and insurance billing workflows.
• For CIOs, ask for API documentation, UAE data residency controls, user permissions, audit logs and integration support for clinic management systems.
• For medical directors, confirm that payment workflows do not expose patient data beyond what is needed for billing and consent.

Typical UAE online card acceptance costs for small merchants are commonly quoted at about 2.5% to 3% plus a fixed charge of around AED 1 per transaction, although clinic pricing depends on volume, card mix, channel and risk category. For supplier transfers, the actionable number is the total AED debit against the beneficiary's received currency. Finance teams should compare the bank statement amount, provider fee, FX rate, settlement date and any intermediary bank charges on at least 10 recent invoices before switching providers.

Insurer and patient implications

The first impact is unlikely to be patient checkout. UAE clinics accepting payments from patients covered by Daman, Thiqa or Sukoon still need payer-specific claims, prior authorisation and reconciliation processes. A payment licence does not change DHA, DOH or MOHAP clinical rules, and it does not replace insurer contracting.

The more immediate use case is cash control. A clinic that pays a foreign laboratory, device distributor or telehealth technology vendor needs a documented payment trail that stands up to audit. If XTransfer receives final CBUAE licensing, operators should ask whether the platform can produce invoice-level references, beneficiary screening records, user approval trails and exportable reports for VAT and corporate tax files.

Eligibility should be verified with the provider after final licensing. Clinics should ask whether XTransfer can onboard mainland companies, free zone entities, sole establishments and branch structures, and whether healthcare businesses are accepted under its risk policy. They should also confirm whether settlements can be made in AED and whether payments to mainland China, Hong Kong, Singapore, the UK and the US are supported under the UAE licence.

What comes next is procedural. XTransfer must satisfy CBUAE pre-issuance conditions before it can operate under the licence. Until then, UAE healthcare operators should treat the approval as a procurement watch item, not a live replacement for existing banking or gateway arrangements. For patients and operators checking licensed healthcare providers, use the UAE Open Healthcare Directory to find licensed clinics and providers by emirate, specialty and regulator.